Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

The growth inhibition of human breast cancer cells by a novel synthetic progestin involves the induction of transforming growth factor beta.
A A Colletta, … , M Baum, M B Sporn
A A Colletta, … , M Baum, M B Sporn
Published January 1, 1991
Citation Information: J Clin Invest. 1991;87(1):277-283. https://doi.org/10.1172/JCI114983.
View: Text | PDF
Research Article Article has an altmetric score of 3

The growth inhibition of human breast cancer cells by a novel synthetic progestin involves the induction of transforming growth factor beta.

  • Text
  • PDF
Abstract

Recent experimental work has identified a novel intracellular binding site for the synthetic progestin, Gestodene, that appears to be uniquely expressed in human breast cancer cells. Gestodene is shown here to inhibit the growth of human breast cancer cells in a dose-dependent fashion, but has no effect on endocrine-responsive human endometrial cancer cells. Gestodene induced a 90-fold increase in the secretion of transforming growth factor-beta (TGF-beta) by T47D human breast cancer cells. Other synthetic progestins had no effect, indicating that this induction is mediated by the novel Gestodene binding site and not by the conventional progesterone receptor. Furthermore, in four breast cancer cell lines, the extent of induction of TGF-beta correlated with intracellular levels of Gestodene binding site. No induction of TGF-beta was observed with the endometrial cancer line, HECl-B, which lacks the Gestodene binding site, but which expresses high levels of progesterone receptor. The inhibition of growth of T47D cells by Gestodene is partly reversible by a polyclonal antiserum to TGF-beta. These data indicate that the growth-inhibitory action of Gestodene may be mediated in part by an autocrine induction of TGF-beta.

Authors

A A Colletta, L M Wakefield, F V Howell, D Danielpour, M Baum, M B Sporn

×

Total citations by year

Year: 2021 2019 2013 2012 2011 2010 2004 2003 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1989 Total
Citations: 1 1 1 1 2 1 1 2 3 2 5 8 6 14 12 9 11 9 3 1 1 94
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (94)

Title and authors Publication Year
Next-Generation Endocrine Therapies for Breast Cancer
DP McDonnell, SE Wardell, CY Chang, JD Norris
Journal of Clinical Oncology 2021
Contribution of the polymorphism rs1800469 of transforming growth factor β in the development of myocardial infarction: meta-analysis of 5460 cases and 8413 controls (MOOSE-compliant article)
L Du, T Gong, M Yao, H Dai, HG Ren, H Wang
Medicine 2019
Tranilast enhances the anti-tumor effects of tamoxifen on human breast cancer cells in vitro
S Darakhshan, A Ghanbari
Journal of Biomedical Science 2013
Factors affecting disease manifestation of toxocarosis in humans: Genetics and environment
CK Fan, CW Liao, YC Cheng
Veterinary Parasitology 2012
Transforming growth factor–β1 variant Leu10Pro is associated with both lack of microfilariae and differential microfilarial loads in the blood of persons infected with lymphatic filariasis
AY Debrah, L Batsa, A Albers, S Mand, MR Toliat, P Nürnberg, O Adjei, A Hoerauf, K Pfarr
Human Immunology 2011
Advances in Cancer Research
M Lemaire, S Deleu, ED Bruyne, EV Valckenborgh, E Menu, K Vanderkerken
Advances in Cancer Research Volume 110 2011
Postmenopausal Hormone Therapy: An Endocrine Society Scientific Statement
RJ Santen, DC Allred, SP Ardoin, DF Archer, N Boyd, GD Braunstein, HG Burger, GA Colditz, SR Davis, M Gambacciani, BA Gower, VW Henderson, WN Jarjour, RH Karas, M Kleerekoper, RA Lobo, JA Manson, J Marsden, KA Martin, L Martin, JA Pinkerton, DR Rubinow, H Teede, DM Thiboutot, WH Utian
The Journal of clinical endocrinology and metabolism 2010
Analysis of the Transforming Growth Factor- β1 Gene Promoter Polymorphisms in Early Osseointegrated Implant Failure
MC Santos, MI Campos, AP Souza, RM Scarel-Caminaga, R Mazzonetto, SR Line
Implant Dentistry 2004
Cancer prevention and therapy: strategies and problems
D Kanduc, F Capuano, SA Capurso, J Geliebter, D Guercia, A Lucchese, A Mittelman, SM Simone, AA Sinha, R Tiwari, E Farber
Journal of Experimental Therapeutics and Oncology 2003
Risk of breast cancer with progestins: critical assessment of current data
RJ Santen
Steroids 2003
Role of transforming growth factor beta in the growth inhibition of human breast cancer cells by basic fibroblast growth factor
E Fenig, Y Kanfi, Q Wang, E Beery, T Livnat, L Wasserman, G Lilling, J Yahalom, R Wieder, J Nordenberg
Breast Cancer Research and Treatment 2001
Estrogen and antiestrogen actions on transforming growth factorβ (Tgfβ) in normal human breast epithelial (HBE) cells
C Malet, F Fibleuil, C Mestayer, I Mowszowicz, F Kuttenn
Molecular and Cellular Endocrinology 2001
Latency, activation, and binding proteins of TGF-?
K Koli, J Saharinen, M Hyytiinen, C Penttinen, J Keski-Oja
Microscopy Research and Technique 2001
Transforming growth factors-beta are not good biomarkers of chemopreventive efficacy in a preclinical breast cancer model system
J Zujewski, A Vaughn-Cooke, KC Flanders, MA Eckhaus, RA Lubet, LM Wakefield
Breast Cancer Research 2000
Transforming growth factors-β are not good biomarkers of chemopreventive efficacy in a preclinical breast cancer model system
JA Zujewski, A Vaughn-Cooke, KC Flanders, MA Eckhaus, RA Lubet, LM Wakefield
Breast Cancer Research 2000
Transforming growth factor beta related to extent of tumor angiogenesis but not apoptosis or proliferation in breast carcinoma
AL Kesari, VG Chellam, BS Mathew, MK Nair, MR Pillai
Breast Cancer 1999
Induction of apoptosis in human breast cancer cells by tocopherols and tocotrienols
W Yu, M Simmons‐Menchaca, A Gapor, BG Sanders, K Kline
Nutrition and Cancer 1999
The Novel Progesterone Receptor Antagonists RTI 3021–012 and RTI3021–022 Exhibit Complex Glucocorticoid Receptor Antagonist Activities: Implications for the Development of Dissociated Antiprogestins*
BL Wagner, G Pollio, P Giangrande, JC Webster, M Breslin, DE Mais, CE Cook, WV Vedeckis, JA Cidlowski, DP McDonnell
Endocrinology 1999
Growth factors, apoptosis, and survival of mammary epithelial cells
E C Rosfjord, R B Dickson
Journal of Mammary Gland Biology and Neoplasia 1999
Dynamics of protein 27 of avian leukosis virus and transforming growth factor beta2 in lymphoid leukosis susceptible and resistant broiler chicken breeding stock
E K Barbour, M Bouljihad, B Hamdar, W Sakr, A Eid, B Safieh-Garabedian
Veterinary Research Communications 1999
Identification of the start sites for the 1.9- and 1.4-kb rat transforming growth factor-β1 transcripts and their effect on translational efficiency
Y Yang, M Mumy, D Romeo, LM Wakefield
Gene 1998
Tissue-Specific and Developmental Regulation of Transforming Growth Factor-β1 Expression in Fetal Lamb Ductus Arteriosus Endothelial Cells
B Zhou, C Coulber, M Rabinovitch
Pediatric Research 1998
Developmental Regulation of the Amount and Subcellular Targeting of the GLUT1 Glucose Transporter in Mouse Mammary Gland ♦ 426
RS Geske, PM Haney
Pediatric Research 1998
Structure–Activity Relationships for Triphenylethylene Antiestrogens on Hepatic Phase-I and Phase-II Enzyme Expression
EF Nuwaysir, YP Dragan, R McCague, P Martin, J Mann, VC Jordan, HC Pitot
Biochemical Pharmacology 1998
Inhibitors of Cell Growth
A Macieira-Coelho
1998
Molecular Basis of Sex Hormone Receptor Function
H Gronemeyer, U Fuhrmann, K Parczyk
1998
5-Aryl-1,2-dihydrochromeno[3,4- f ]quinolines: A Novel Class of Nonsteroidal Human Progesterone Receptor Agonists
L Zhi, CM Tegley, EA Kallel, KB Marschke, DE Mais, MM Gottardis, TK Jones
Journal of Medicinal Chemistry 1998
The potential influence of radiation-induced microenvironments in neoplastic progression
M H Barcellos-Hoff
Journal of Mammary Gland Biology and Neoplasia 1998
Estrogen accelerates cutaneous wound healing associated with an increase in TGF-β1 levels
GS Ashcroft, J Dodsworth, EV Boxtel, RW Tarnuzzer, MA Horan, GS Schultz, MW Ferguson
Nature Medicine 1997
Latent transforming growth factor-β: Structural features and mechanisms of activation
JS Munger, JG Harpel, PE Gleizes, R Mazzieri, I Nunes, DB Rifkin
Kidney International 1997
Evidence for role of transforming growth factor‐β in RRR‐a‐tocopheryl succinate‐induced apoptosis of human mda‐mb‐435 breast cancer cells
W Yu, K Heim, M Qian, M Simmons‐Menchaca, BG Sanders, K Kline
Nutrition and Cancer 1997
Growth Factors and Cytokines in Health and Disease
P Martin, J McCluskey, P Mallucci, S Nodder
Growth Factors and Cytokines in Health and Disease 1997
Transforming growth factor-β, other growth factors, and the extracellular matrix
MA Haralson
Journal of Laboratory and Clinical Medicine 1997
Blockade of Transforming Growth Factor-β Signaling Does Not Abrogate Antiestrogen-induced Growth Inhibition of Human Breast Carcinoma Cells
KM Koli, TT Ramsey, Y Ko, TC Dugger, MG Brattain, CL Arteaga
The Journal of biological chemistry 1997
Role of TGFβ in the anti-estrogen response/resistance of human breast cancer
JR Benson, M Baum, AA Colletta
Journal of Mammary Gland Biology and Neoplasia 1996
Complex role of tumor cell transforming growth factor (TGF)-βs on breast carcinoma progression
KM Koli, CL Arteaga
Journal of Mammary Gland Biology and Neoplasia 1996
Growth factor and sex steroid interactions in breast cancer
NJ Kenney, RB Dickson
Journal of Mammary Gland Biology and Neoplasia 1996
Calcitriol and lexicalcitol (kh1060) inhibit the growth of human breast adenocarcinoma cells by enhancing transforming growth factor-β production
T Mercier
Biochemical Pharmacology 1996
Altered expression of transforming growth factor-β1 in cervical neoplasia as an early biomarker in carcinogenesis of the uterine cervix
JT Comerci, CD Runowicz, KC Flanders, CD Victoria, AL Fields, AS Kadish, GL Goldberg
Cancer 1996
Growth inhibition by anti-estrogens and progestins in TGF-β-resistant and -sensitive breast-tumor cells
E Kalkhoven, E Beraldi, ML Panno, JP de Winter, JH Thijssen, BV der Burg
International Journal of Cancer 1996
Changes in expression of transforming growth factor beta mRNA isoforms in patients undergoing tamoxifen therapy
J MacCallum, JC Keen, JM Bartlett, AM Thompson, JM Dixon, WR Miller
British Journal of Cancer 1996
Modulation of murine EL‐4 thymic lymphoma cell proliferation and cytokine production by vitamin E succinate
W Yu, BG Sanders, K Kline
Nutrition and Cancer 1996
RRR‐α‐tocopheryl succinate enhances TGF‐β<sub>1</sub>, ‐β<sub>2</sub>, and ‐β<sub>3</sub> and TGF‐βR‐II expression by human MDA‐MB‐435 breast cancer cells
A Charpentier, M Simmons‐Menchaca, W Yu, B Zhao, M Qian, K Heim, BG Sanders, K Kline
Nutrition and Cancer 1996
Inhibition of growth and induction of TGF-β1 in human hepatocellular carcinoma with androgen receptor by cyproterone acetate in male nude mice
N Nagasue, L Yu, M Yamaguchi, H Kohno, M Tachibana, H Kubota
Journal of Hepatology 1996
The multifunctional role of transforming growth factor (TGF)-beta s on mammary epithelial cell biology
CL Arteaga, TC Dugger, SD Hurd
Breast Cancer Research and Treatment 1996
Feedback Mechanism of Focal Vascular Lesion Formation in Transgenic Apolipoprotein(a) Mice
RM Lawn, AD Pearle, LL Kunz, EM Rubin, J Reckless, JC Metcalfe, DJ Grainger
The Journal of biological chemistry 1996
Mammary Tumor Cell Cycle, Differentiation, and Metastasis
RB Dickson, ME Lippman
1996
Induction of TGF-beta by an antiprogestin in the human breast cancer cell line T-47D
C Dannecker, K Possinger, S Classen
Annals of Oncology 1996
Mechanisms of action of endocrine treatment in breast cancer
PE Lønning, EA Lien
Critical Reviews in Oncology/Hematology 1995
A PIVOTAL ROLE FOR TGF-β* IN ATHEROGENESIS?
DJ Grainger, JC Metcalfe
Biological Reviews 1995
Transforming growth factor beta secretion from primary breast cancer fibroblasts
CE Roozendaal, JG Klijn, B Ooijen, C Claassen, AM Eggermont, SC Henzen-Logmans, JA Foekens
Molecular and Cellular Endocrinology 1995
The role of TGF-β production in growth inhibition of breast-tumor cells by progestins
E Kalkhoven, L Kwakkenbos-Isbrücker, CL Mummery, SW de Laat, AJ van Raaij, PT van der Saag, BV der Burg
International Journal of Cancer 1995
Correlation of TGF-(Si Expression with Medroxiprogesterone Acetate Responsiveness in Mouse Mammary Adenocarcinomas
PV Elizalde, FK Guerra, M Gravano, C Lanari, ME Lippman, EH Charreau, R Lupu
Cancer Investigation 1995
Transforming growth factor $beta; and cancer
P Norgaard, S Hougaard, HS Poulsen, M Spang-Thomsen
Cancer Treatment Reviews 1995
Active and acid-activatable TGF-β in human sera, platelets and plasma
DJ Grainger, DE Mosedale, JC Metcalfe, PL Weissberg, PR Kemp
Clinica Chimica Acta 1995
Characterization of Binding of Transforming Growth Factor-β1 to Bovine Mammary Membranes
K Plaut, RL Maple
Journal of Dairy Science 1995
Transforming Growth Factor β: Prospects for Cancer Prevention and Treatment
JR Benson, AA Colletta
Clinical immunotherapeutics 1995
Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: I. MCF-7 cell lines
WG Schoonen, JW Joosten, HJ Kloosterboer
The Journal of Steroid Biochemistry and Molecular Biology 1995
Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: II. T47D cell lines
WG Schoonen, JW Joosten, HJ Kloosterboer
The Journal of Steroid Biochemistry and Molecular Biology 1995
Gestodene: A Review of its Pharmacology, Efficacy and Tolerability in Combined Contraceptive Preparations
MI Wilde, JA Balfour
Drugs 1995
Alternative mechanisms of action of anti-oestrogens
AA Colletta, JR Benson, M Baum
Breast Cancer Research and Treatment 1994
Synthetic progestins induce proliferation of breast tumor cell lines via the progesterone or estrogen receptor
E Kalkhoven, L Kwakkenbos-Isbrücker, SW de Laat, PT van der Saag, B der Burg
Molecular and Cellular Endocrinology 1994
Induction of transforming growth factor beta in hormonally treated human prostate cancer
GH Muir, A Butta, RJ Shearer, C Fisher, DP Dearnaley, KC Flanders, MB Sporn, AA Colletta
British Journal of Cancer 1994
Enhanced translational efficiency of a novel transforming growth factor beta 3 mRNA in human breast cancer cells
BA Arrick, RL Grendell, LA Griffin
Molecular and cellular biology 1994
Transforming growth factor beta isoforms in breast cancer
JR Benson, M Baum
British Journal of Cancer 1994
Advances in Pharmacology
B Drenger, Y Ginosar, Y Gozal
Advances in Pharmacology 1994
Effects of progestagens and Org OD14 in in vitro and in vivo tumor models
HJ Kloosterboer, WG Schoonen, GH Deckers, JG Klijn
The Journal of Steroid Biochemistry and Molecular Biology 1994
Growth Factors and Their Receptors
D Tripathy, C Benz
Hematology/Oncology Clinics of North America 1994
High dose toremifene in advanced breast cancer resistant to or relapsed during tamoxifen treatment
S Pyrhnen, R Valavaara, J Vuorinen, A Hajba
Breast Cancer Research and Treatment 1994
An appraisal of strategies to reduce the incidence of breast cancer
VC Jordan, M Morrow
Stem Cells 1993
Challenges: The pharmacological manipulation of members of the transforming growth factor beta family in the chemoprevention of breast cancer
TA Dickens, AA Colletta
BioEssays 1993
Synthetic Progestins in Breast Tumor Cells
E Kalkhoven, L Kwakkenbos-Isbrücker, SW Laat, B Burg
Annals of the New York Academy of Sciences 1993
Transforming growth factor-beta 1 as a signal for induction of cell death by apoptosis
W Bursch, F Oberhammer, RL Jirtle, M Askari, R Sedivy, B Grasl-Kraupp, AF Purchio, R Schulte-Hermann
British Journal of Cancer 1993
Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cells
S Kojima, K Nara, DB Rifkin
The Journal of Cell Biology 1993
Norgestrel and gestodene stimulate breast cancer cell growth through an oestrogen receptor mediated mechanism
WH Catherino, MH Jeng, VC Jordan
British Journal of Cancer 1993
Role of Epidermal Growth Factor and Transforming Growth Factors in Mammary Development and Lactation
K Plaut
Journal of Dairy Science 1993
Improved sandwich enzyme-linked immunosorbent assays for transforming growth factor β1
D Danielpour
Journal of Immunological Methods 1993
Cellular and Molecular Biology of Bone
M Demay, H Jüppner, AB Abou-Samra, G Segre, H Kronenberg
Cellular and Molecular Biology of Bone 1993
Transforming Growth Factor-β: Latent Forms, Binding Proteins and Receptors
K Miyazono, H Ichijo, CH Heldin
Growth Factors 1993
A Risk-Benefit Assessment of Tamoxifen Therapy:
WH Catherino, VC Jordan
Drug Safety 1993
Differential expression of the TGF-? isoforms in embryogenesis suggests specific roles in developing and adult tissues
AB Roberts, MB Sporn
Molecular Reproduction and Development 1992
TGF-β stimulation of endometrial and breast-cancer cell growth
JD Croxtall, A Jamil, M Ayub, AA Colletta, JO White
International Journal of Cancer 1992
Differential regulation of the expression of transforming growth factor-? mRNAs by growth factors and retinoic acid in chicken embryo chondrocytes, myocytes, and fibroblasts
SB Jakowlew, J Cubert, D Danielpour, MB Sporn, AB Roberts
Journal of Cellular Physiology 1992
Transforming growth factor-beta mRNA expression and growth control of human ovarian carcinoma cells
JM Bartlett, GJ Rabiasz, WN Scott, SP Langdon, JF Smyth, WR Miller
British Journal of Cancer 1992
Glioblastoma, transforming growth factor-β, and Candida meningitis: A potential link
PK Peterson, CC Chao, S Hu, K Thielen, EG Shaskan
The American Journal of Medicine 1992
Control of transforming growth factor-β activity: Latency vs. activation
JG Harpel, CN Metz, S Kojima, DB Rifkin
Progress in Growth Factor Research 1992
Effects of progestins on the proliferation of estrogen-dependent human breast cancer cells under growth factor-defined conditions
B der Burg, E Kalkhoven, L Isbrücker, SW de Laat
The Journal of Steroid Biochemistry and Molecular Biology 1992
Transforming growth factor-β isoforms in mammary neoplasia: More questions than answers
CL Arteaga, RJ Coffey
Human Pathology 1992
Control of Growth Factors and Prevention of Cancer
MB Sporn
1992
Differential regulation of the expression of transforming growth factor-?s 1 and 2 by retinoic acid, epidermal growth factor, and dexamethasone in NRK-49F and A549 cells
D Danielpour, KY Kim, TS Winokur, MB Sporn
Journal of Cellular Physiology 1991
Cloning and Overexpression of TGF-β1 cDNA in a Mammary Adenocarcinoma: In Vitro and In Vivo Effects
D Theodorescu, D Bergsma, MS Man, N Elshourbagy, C Sheehan, D Rieman, RS Kerbel
Growth Factors 1991
Genes, Oncogenes, and Hormones
RB Dickson, ME Lippman
1991
Novel approaches to the endocrine therapy of breast cancer
M Dowsett
European Journal of Cancer and Clinical Oncology 1990
Contraception
MD Gillmer
Contraception 1989

← Previous 1 2 3 4 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 3 patents
14 readers on Mendeley
See more details